mRNA |
Irinotecan |
FIMM |
pan-cancer |
AAC |
0.44 |
0.0006 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0006 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0009 |
mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0009 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
phenformin |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |